Mesalamine Tablet, Delayed Release
Product Images NDC 31722-043

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 31722-043). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Camberlogo (Camberlogo)

FDA Label Image

Mesalaminedrtablets120tablets (Mesalaminedrtablets120tablets)

This text provides information about Mesalamine Delayed-Release Tablets, USP, with a dosage of 1.2g per tablet for once-daily use. The tablets should be stored at 20°C to 25°C, and pharmacists are advised to dispense them in light-resistant containers. The package insert should be consulted for dosage information, and the medication should be kept out of the reach of children. The tablets are manufactured for Camber Pharmaceuticals, Inc., and further details about the manufacturing license and the manufacturer are provided.*

FDA Label Image

Mesalaminedrtabsstructure (Mesalaminedrtabsstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.